Medicare Advantage Stars

CMS’s 2027 Medicare Advantage final rule is intensifying the tension between Stars-driven payment strategy and beneficiary protection: the Trump administration finalized MA policies that strengthen some consumer safeguards while rolling back others, alongside Star Ratings changes that affect plan revenue and competitive positioning (KFF). At the same time, payer commentary and Q1 signals point to an MA model under pressure—margin compression, prior authorization reform, rapid membership growth, and AI scaling are converging, making Stars performance, utilization management, and risk-adjusted growth more consequential for MA plans, delegated risk groups, and VBC providers. CMS reporting requirements and quality-measure audit scrutiny across Medicare programs reinforce the broader pattern: quality data integrity is becoming a direct reimbursement and contracting risk, not just a compliance function.